ASBrS: Robotic Nipple-Sparing Mastectomy Safe, Effective in Early Breast Cancer

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 4, 2026.

via HealthDay

MONDAY, May 4, 2026 -- For patients with early-stage breast cancer, robotic nipple-sparing mastectomy (rNSM) is as safe and effective as open NSM, according to a study presented at the annual meeting of the American Society of Breast Surgeons, held from April 29 to May 3 in Seattle.

Katherine Kopkash, M.D., from the University of Chicago Pritzker School of Medicine in Evanston, Illinois, and colleagues examined the safety and effectiveness of rNSM using the da Vinci Single Port versus open NSM among women with early-stage breast cancer (clinical Tis-T2 and N0). Patients were randomly assigned to rNSM or open NSM (37 patients in each arm).

The researchers found that none of the patients in the rNSM arm required conversion to an open procedure. At 42 days, serious adverse events (SAEs) occurred in 8.1 and 21.6 percent of rNSM and NSM patients, respectively. No device-related SAEs occurred in the rNSM group. At 42 days, nipple-areolar complex preservation was 100 and 98.5 percent in the rNSM and open NSM groups, respectively. Unplanned reoperations occurred in 5.4 and 21.6 percent of patients in the rNSM and open NSM groups, respectively. The positive surgical margin rate was 16.2 percent in both groups. There was no significant difference seen in the rate of "ink on tumor" or ductal carcinoma in situ ≤2 mm from the margin. None of the trial patients had local or distant recurrences of cancer. More favorable baseline to six-month changes were seen in the rNSM group versus the open NSM group in the BREAST-Q domains of sexual well-being, satisfaction with breasts, and physical well-being chest, although they were not significant.

"Robotic breast surgery may have real benefits for both the patients and surgeons," Kopkash said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-05 02:23

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords